This episode explores the therapeutic potential of exosomes, focusing on their differences from stem cells and their current regulatory status. Against the backdrop of the FDA considering exosomes as drugs, approved only for topical cosmetic use, the discussion delves into their production from umbilical cord lining stem cells, highlighting the importance of source and purity. More significantly, the interview details the composition of a specific exosome product, including secretomes, hyaluronic acid, collagen, and beta-defensins, emphasizing that the presence of exosomes alone is insufficient for therapeutic efficacy. For instance, the guest describes his personal experience using exosomes for hair growth, showcasing accelerated results in a hair transplant procedure. The conversation then pivots to various application methods, such as intravenous infusions and nebulization for lung health, alongside a discussion of potential risks and contraindications. Finally, the episode touches upon the future of exosome research, including potential applications in chronic diseases and the development of exosome-based supplements, concluding with a discussion on the importance of pre-treatment body preparation to optimize exosome effectiveness.
Sign in to continue reading, translating and more.
Continue